New Medicare Advantage Compliance Program Guidance Released
The Office of Inspector General (OIG) under the U.S. Department of Health and Human Services has released new compliance program guidance tailored for the Medicare Advantage (MA) sector. Known as the Medicare Advantage Industry Segment-Specific Compliance Program Guidance (ICPG), it updates nearly 30-year-old directives by highlighting enforcement priorities for Medicare Advantage organizations (MAOs), as well as related providers and vendors.
Published alongside the November 2023 General Compliance Program Guidance, the ICPG reflects a move towards targeted compliance guidelines for different healthcare industries. Following nursing facilities, Medicare Advantage is the second segment to receive these focused guidelines, with plans to include hospitals and pharmaceutical manufacturing, albeit with unspecified release dates.
The ICPG outlines major compliance areas, serving as a guide for stakeholders in the MA space. Although not legally binding, it specifies OIG’s compliance expectations and enforcement goals. The highlighted areas include network adequacy, provider directories, and utilization management requiring careful oversight, particularly in the context of AI-driven technologies in prior authorization processes.
Access to Care: Network Adequacy and Prior Authorization
MAOs are urged to ensure sufficient provider networks and maintain accurate provider directories to prevent beneficiary harm and potential False Claims Act (FCA) violations. Careful monitoring of provider availability and timely directory updates is essential. Utilization management should balance AI tools with clinical judgment, monitoring denial rates to better serve individual patient needs.
Marketing and Enrollment: Financial Incentives and Ethical Practices
To mitigate FCA risk, MAOs need to examine compensation models that may incentivize behaviors not aligned with beneficiaries' interests. Training and rigorous monitoring systems are recommended. Accuracy in marketing, including clear communication and thorough review of marketing materials, is vital to prevent misleading practices.
Risk Adjustment and Quality of Care
Ensuring data integrity in risk adjustment is crucial, involving regular audits and employing data filtering to maintain the accuracy of risk assessments and diagnosis codes. Accurate reporting for Star Ratings is essential, with MAOs required to confirm data quality and compliance, avoiding including individuals from CMS's Preclusion List.
Compliance for MAOs, even with delegated functions, remains critical under OIG’s directives. Conducting pre-contract assessments and integrating compliance provisions in contracts are advised practices. The ICPG provides MA entities a strategic framework to bolster compliance, mitigate risks, and navigate the regulatory landscape of Medicare Advantage efficiently.